Hinweis zur Verwendung von Cookies

Zur Bereitstellung und Optimierung unseres Webauftritts möchten wir gerne statistische Informationen vollständig anonymisiert erfassen und analysieren. Dürfen wir hierzu vorübergehend einen Statistik-Cookie setzen?

Sie können Ihre Einwilligung jederzeit in unserer Datenschutzerklärung widerrufen.

Article "Safety, immunogenicity and interchangeability of Biosimilars - monoclonal antibodies and fusion proteins with antibody moiety in focus" (from: Bulletin on Drug Safety – Issue 4/2021, p. 19 to 24) (German only)

date of issue 03.01.2022

file

file "Article "Safety, immunogenicity and interchangeability of Biosimilars - monoclonal antibodies and fusion proteins with antibody moiety in focus" (from: Bulletin on Drug Safety – Issue 4/2021, p. 19 to 24) (German only)"download(PDF, 90KB, File does not meet accessibility standards.)

Updated: 03.01.2022

Paul-Ehrlich-Institut

Hinweis zur Verwendung von Cookies

You are here

Article "Safety, immunogenicity and interchangeability of Biosimilars - monoclonal antibodies and fusion proteins with antibody moiety in focus" (from: Bulletin on Drug Safety – Issue 4/2021, p. 19 to 24) (German only)

file

You are here:

Paul-Ehrlich-Institut

Hinweis zur Verwendung von Cookies

You are here

Article "Safety, immunogenicity and interchangeability of Biosimilars - monoclonal antibodies and fusion proteins with antibody moiety in focus" (from: Bulletin on Drug Safety – Issue 4/2021, p. 19 to 24) (German only)

file

You are here:

Share content with